Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Cagrilintide, Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - large image1
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - image1
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - image2
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - image3
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - image4
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - image5
Cagrilintide,  Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator buy - image6

Cagrilintide, Weight Management Substance, Satiety Enhancer, Lipid Metabolism Modulator

59 Inquiries

Unit Price:

$100-130/G FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pesticide Grade

Content:

99%

Port:

qingdao

Brand:

sinov

Packaging:

25kg/drum

Price valid (until):

2026-09-12

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Product Description
    Cagrilintide is a synthetic long-acting polypeptide raw material, white lyophilized powder with HPLC purity ≥99%. It works by targeting receptors to regulate multiple metabolic pathways in the body. The molecular structure is optimized for stable properties, excellent solubility and controllable impurities, suitable for solid oral formulations and functional compound formula development. Widely applied in metabolic health product development and biomedical mechanism research globally. It is commonly combined with active substances in formula research to achieve synergistic metabolic regulation effects.
    Core Efficacy
    Modulates appetite signals naturally, extends lasting satiety, reduces frequent food cravings and intake of high-calorie food, supports steady calorie control and gradual body mass management.
    Regulates gastric emptying rhythm, slows down nutrient digestion and absorption speed, avoids rapid energy surge after meals and reduces excess energy conversion into fat storage.
    Optimizes whole-body lipid metabolism, inhibits excessive fat accumulation, especially reduces visceral fat buildup, and helps improve disorders related to unbalanced metabolism.
    Supports stable energy balance in the body, assists in maintaining healthy body composition under reasonable diet and daily activity conditions.
    Cooperates with other metabolic active ingredients to bring synergistic regulating effects, enhances comprehensive metabolic conditioning results in compound formulas.
    Improves abnormal eating habits caused by metabolic imbalance, helps reduce frequent overeating and emotional eating tendency.
    Maintains steady metabolic activity for a long cycle, supports continuous metabolic adjustment and avoids sharp fluctuations of energy balance.
    Application Scenarios
    Metabolic health functional raw materials: Used to develop oral weight management formulations for sub-health groups with excess body weight and disordered metabolism.
    Compound active formula research: Matched with other metabolic regulating raw materials for developing multi-target metabolic conditioning health products.
    Biomedical laboratory research: Applied for  receptor pathway research, metabolic mechanism exploration and new formula development tests.
    Sub-health daily conditioning products: Core raw material for nutritional formulas targeting people with uncontrolled appetite and sedentary metabolic slowdown.
    High-end nutritional research projects: Raw material for developing long-cycle metabolic balance formulations suitable for long-term daily conditioning.
    Academic pharmacological research: Used for comparative study of multi-target metabolic regulating peptides and formulation screening experiments.

    Shop Cagrilintide, Amylin Receptor Agonist, Pharmaceutical Grade Peptide,Metabolic Regulator-Detailed Image 1 Shop Cagrilintide, Amylin Receptor Agonist, Pharmaceutical Grade Peptide,Metabolic Regulator-Detailed Image 2

    Items Specifications
    Origin China
    Purity 99
    Appearance powder
    Color white
    Package Drum, Plastic Container, Vacuum Packed
    Storage 2 years
    Shelf life Cool Dry Place
    ECHEMI Editorial Reference
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    59 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.